Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary: 1. The inflammatory state, which is associated with the current pandemic of obesity, has been established as an important contributing pathogenic factor to the increased prevalence of the so‐called metabolic syndrome. Many studies have focused on the contribution of various adipokines to this phenomenon, and in the present study, we provide an update on the emerging evidence that the pro‐inflammatory factor, lipocalin‐2, might influence various aspects of metabolic syndrome. 2. Previous reports indicate a positive correlation of serum lipocalin‐2 with fasting glucose, the homeostasis model assessment of insulin resistance index, and the inflammatory marker high‐sensitivity C‐reactive protein, even after adjustment for body mass index, suggesting that it is an independent risk factor for insulin resistance, diabetes, and inflammation. Direct analysis of lipocalin‐2 action now also shows effects on peripheral metabolism and on cardiovascular function. 3. A better understanding of how lipocalin‐2 is regulated locally and systemically is crucial for adding to our understanding of the pathogenesis of metabolic syndrome, and to uncover potential new avenues for therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877 · cited 1×
“Lipocalin-2 was initially discovered to play an important role in the innate immune response to bacterial infection.(7,8) Lipocalin-2 knockout mice display an increased susceptibility to bacterial infections due to the failure of iron sequestration.”
BackgroundThe lipocalin protein family: structural and sequence overview
Flower, D. R., North, A. C. T., & Sansom, C. E. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00148-5 · Cited by 868
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · cited 1×
“Clearly, pro-inflammatory mechanisms might contribute to various aspects of cardiac remodelling.(42) More specifically, since lipocalin2 potently binds to MMP-9, it has been proposed that this means of regulating extracellular matrix remodelling 43 might be important in controlling cardiac fibrosis and the vascular re…”
BackgroundSelf-citationWang, Y., Lam, K. S. L., Kraegen, E. W., Sweeney, G., Zhang, J., Tso, A. W., Chow, W.-S., Wat, N. M., Xu, J. Y., Hoo, R. L., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.075614 · Cited by 578 · cited 3×
“A strong, positive association was observed between lipocalin-2 concentrations and hs-CRP, which was independent of age, sex, and adiposity.(14) Indeed, the expression of lipocalin-2 is generally elevated by agents that promote insulin resistance and is reduced by thiazolidinediones.”
BackgroundSelf-citationHuman neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse
Kjeldsen, L., Cowland, J. B., & Borregaard, N. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00152-7 · Cited by 368
The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2
Fischbach, M. A., Lin, H., Zhou, L., Yu, Y., Abergel, R. J., Liu, D. R., Raymond, K. N., Wanner, B. L., Strong, R. K., Walsh, C. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604636103 · Cited by 319 · cited 1×
“Lipocalin-2 was initially discovered to play an important role in the innate immune response to bacterial infection.(7,8) Lipocalin-2 knockout mice display an increased susceptibility to bacterial infections due to the failure of iron sequestration.”
BackgroundThe metabolic syndrome: time to get off the merry-go-round?: Review: The metabolic syndrome
Reaven, G. M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02325.x · Cited by 214 · cited 1×
“Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular diseases or diabetes.(1) The most well-accepted, up-to-date definition of metabolic syndrome was established by the International Diabetes Federation, which states that individuals with metabolic syndrome exhib…”
Background
Cited by
Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine
Nimptsch, K., Konigorski, S., & Pischon, T. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.006 · Cited by 314
The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases
Abella, V., Scotece, M., Conde, J., Gómez, R., Lois, A., Pino, J., Gómez-Reino, J. J., Lago, F., Mobasheri, A., & Gualillo, O. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1123354 · Cited by 288
Recinella, L., Orlando, G., Ferrante, C., Chiavaroli, A., Brunetti, L., & Leone, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.578966 · Cited by 261
Adipokines in gestational diabetes
Fasshauer, M., Blüher, M., & Stumvoll, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70176-1 · Cited by 230
Diverse functional roles of lipocalin-2 in the central nervous system
Jha, M. K., Lee, S., Park, D. H., Kook, H., Park, K.-G., Lee, I.-K., & Suk, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.006 · Cited by 195
Metadata
- Authors
- Jang, Y., Lee, J. H., Wang, Y., & Sweeney, G.
- Venue
- Clinical and Experimental Pharmacology and Physiology
- Publisher
- Wiley
- Published
- 2012-01-30
- Volume
- 39
- Issue
- 2
- Pages
- 194-199
- ISSN
- 0305-1870 (ISSN-L)
- 1440-1681
- OpenAlex
- W2159493243
- Cited by
- 64
- References
- 7
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome. https://app.cochat.ai/papers/10.1111/j.1440-1681.2011.05557.x
- The paper
- Jang, Y., Lee, J. H., Wang, Y., & Sweeney, G. (2012). Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2011.05557.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.